125 related articles for article (PubMed ID: 11038008)
1. Treatment of SW620 cells with Tomudex and oxaliplatin induces changes in 2-deoxy-D-glucose incorporation associated with modifications in glucose transport.
Smith TA; Maisey NR; Titley JC; Jackson LE; Leach MO; Ronen SM
J Nucl Med; 2000 Oct; 41(10):1753-9. PubMed ID: 11038008
[TBL] [Abstract][Full Text] [Related]
2. Involvement of bcl-2 and p21waf1 proteins in response of human breast cancer cell clones to Tomudex.
Orlandi L; Bearzatto A; Abolafio G; De Marco C; Daidone MG; Zaffaroni N
Br J Cancer; 1999 Sep; 81(2):252-60. PubMed ID: 10496350
[TBL] [Abstract][Full Text] [Related]
3. Influence of resistance to 5-fluorouracil and tomudex on [18F]‑FDG incorporation, glucose transport and hexokinase activity.
Law AA; Collie-Duguid ES; Smith TA
Int J Oncol; 2012 Jul; 41(1):378-82. PubMed ID: 22576694
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxicity of antifolate inhibitors of thymidylate and purine synthesis to WiDr colonic carcinoma cells.
Smith SG; Lehman NL; Moran RG
Cancer Res; 1993 Dec; 53(23):5697-706. PubMed ID: 8242626
[TBL] [Abstract][Full Text] [Related]
5. 2-Deoxy-D-[1-3H]glucose uptake by MCF7 and T47D breast tumour cells under conditions of active proliferation and serum deprivation.
Smith TA; Title JC; Eccles SA; McCready VR
Anticancer Res; 1998; 18(3A):1865-9. PubMed ID: 9673417
[TBL] [Abstract][Full Text] [Related]
6. Dinaline inhibits amino acid transport and proliferation of colon carcinoma cells in vitro.
Schaider H; Haberkorn U; Stöhr M; Berger MR
Anticancer Res; 1995; 15(6B):2501-9. PubMed ID: 8669814
[TBL] [Abstract][Full Text] [Related]
7. Modulation of glucose uptake in a human choriocarcinoma cell line (BeWo) by dietary bioactive compounds and drugs of abuse.
Araújo JR; Gonçalves P; Martel F
J Biochem; 2008 Aug; 144(2):177-86. PubMed ID: 18424810
[TBL] [Abstract][Full Text] [Related]
8. Exposure-response relationships for oxaliplatin-treated colon cancer cells.
Kirstein MN; Root SA; Moore MM; Wieman KM; Williams BW; Jacobson PA; Marker PH; Tuttle TM
Anticancer Drugs; 2008 Jan; 19(1):37-44. PubMed ID: 18043128
[TBL] [Abstract][Full Text] [Related]
9. Glucose transport and apoptosis after gene therapy with HSV thymidine kinase.
Haberkorn U; Altmann A; Kamencic H; Morr I; Traut U; Henze M; Jiang S; Metz J; Kinscherf R
Eur J Nucl Med; 2001 Nov; 28(11):1690-6. PubMed ID: 11702112
[TBL] [Abstract][Full Text] [Related]
10. Colorectal tumor cells treated with 5-FU, oxaliplatin, irinotecan, and cetuximab exhibit changes in 18F-FDG incorporation corresponding to hexokinase activity and glucose transport.
Sharma RI; Smith TA
J Nucl Med; 2008 Aug; 49(8):1386-94. PubMed ID: 18632807
[TBL] [Abstract][Full Text] [Related]
11. Cell cycle arrest and apoptosis induced by oxaliplatin (L-OHP) on four human cancer cell lines.
William-Faltaos S; Rouillard D; Lechat P; Bastian G
Anticancer Res; 2006; 26(3A):2093-9. PubMed ID: 16827150
[TBL] [Abstract][Full Text] [Related]
12. Oxaliplatin, a potent inhibitor of survivin, enhances paclitaxel-induced apoptosis and mitotic catastrophe in colon cancer cells.
Fujie Y; Yamamoto H; Ngan CY; Takagi A; Hayashi T; Suzuki R; Ezumi K; Takemasa I; Ikeda M; Sekimoto M; Matsuura N; Monden M
Jpn J Clin Oncol; 2005 Aug; 35(8):453-63. PubMed ID: 16024531
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia-Induced increase in FDG uptake in MCF7 cells.
Burgman P; Odonoghue JA; Humm JL; Ling CC
J Nucl Med; 2001 Jan; 42(1):170-5. PubMed ID: 11197971
[TBL] [Abstract][Full Text] [Related]
14. Interaction of tomudex with radiation in vitro and in vivo.
Teicher BA; Ara G; Chen YN; Recht A; Coleman CN
Int J Oncol; 1998 Sep; 13(3):437-42. PubMed ID: 9683775
[TBL] [Abstract][Full Text] [Related]
15. Corticosterone suppresses insulin- and NO-stimulated muscle glucose uptake in broiler chickens (Gallus gallus domesticus).
Zhao JP; Lin H; Jiao HC; Song ZG
Comp Biochem Physiol C Toxicol Pharmacol; 2009 Apr; 149(3):448-54. PubMed ID: 19000934
[TBL] [Abstract][Full Text] [Related]
16. Greater cell cycle inhibition and cytotoxicity induced by 2-deoxy-D-glucose in tumor cells treated under hypoxic vs aerobic conditions.
Maher JC; Krishan A; Lampidis TJ
Cancer Chemother Pharmacol; 2004 Feb; 53(2):116-22. PubMed ID: 14605866
[TBL] [Abstract][Full Text] [Related]
17. Oxaliplatin induces drug resistance more rapidly than cisplatin in H69 small cell lung cancer cells.
Stordal BK; Davey MW; Davey RA
Cancer Chemother Pharmacol; 2006 Aug; 58(2):256-65. PubMed ID: 16283310
[TBL] [Abstract][Full Text] [Related]
18. Serine/threonine protein phosphatase inhibition enhances the effect of thymidylate synthase inhibition.
Sakoff JA; Howitt IJ; Ackland SP; McCluskey A
Cancer Chemother Pharmacol; 2004 Mar; 53(3):225-32. PubMed ID: 14648018
[TBL] [Abstract][Full Text] [Related]
19. Short-term exposure of multicellular tumor spheroids of a human glioma cell line to the glycolytic inhibitor 2-deoxy-D-glucose is more toxic than continuous exposure.
Khaitan D; Chandna S; Dwarakanath SB
J Cancer Res Ther; 2009 Sep; 5 Suppl 1():S67-73. PubMed ID: 20009299
[TBL] [Abstract][Full Text] [Related]
20. Tumor cell spheroids as a model for evaluation of metabolic changes after irradiation.
Senekowitsch-Schmidtke R; Matzen K; Truckenbrodt R; Mattes J; Heiss P; Schwaiger M
J Nucl Med; 1998 Oct; 39(10):1762-8. PubMed ID: 9776284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
